(Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | (Q3)Sep 30, 2022 | (Q2)Jun 30, 2022 | (Q1)Mar 31, 2022 | (FY)Dec 31, 2021 | (Q4)Dec 31, 2021 | |
---|---|---|---|---|---|---|---|---|---|---|
Total revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Operating revenue | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
Cost of revenue | ||||||||||
Gross profit | ||||||||||
Operating expense | -96.87%16.7K | -84.98%158.39K | -51.97%385.89K | 120.41%4.14M | 42.62%1.76M | 81.15%532.57K | 1.05M | 368.78%803.44K | 1.88M | 1.24M |
Selling and administrative expenses | -97.91%8.31K | -97.45%15.57K | -71.82%116.36K | 0.43%1.24M | -123.39%-177.41K | 59.14%396.7K | --611.4K | 311.17%412.98K | --1.24M | --758.64K |
-Selling and marketing expense | --0 | -97.18%2.45K | 64.29%38.75K | 29.32%138.69K | -54.93%19.12K | -67.08%9.05K | --86.93K | 120.78%23.59K | --107.24K | --42.42K |
-General and administrative expense | -97.86%8.31K | -97.50%13.12K | -80.07%77.61K | -2.31%1.1M | -127.44%-196.53K | 74.79%387.64K | --524.47K | 333.83%389.4K | --1.13M | --716.22K |
Research and development costs | --0 | -99.29%2.62K | -67.18%108K | 223.67%1.51M | 111.61%768.55K | 1,026.00%41.28K | --366.68K | 363.89%329.11K | --465.17K | --363.2K |
-Depreciation and amortization | 194.06%6.83K | 80.27%6.83K | 697.66%6.83K | 69.91%3.42K | -23,520.00%-3.54K | 128.77%2.32K | --3.79K | --856 | --2.01K | ---15 |
Other operating expenses | -99.67%83 | -91.33%2.49K | -3.19%12.32K | 13.45%76.12K | --21K | --25.1K | --28.75K | --12.73K | --67.09K | ---- |
Operating profit | 96.87%-16.7K | 84.98%-158.39K | 51.97%-385.89K | -120.41%-4.14M | -42.62%-1.76M | -81.15%-532.57K | -1.05M | -368.78%-803.44K | -1.88M | -1.24M |
Net non-operating interest income (expenses) | -150 | 0 | ||||||||
Non-operating interest expense | --150 | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- |
Other net income (expenses) | ||||||||||
Special income (charges) | --0 | --0 | --0 | ---2.92M | --16.01K | ---3.18K | --96.78K | ---3.03M | --0 | --0 |
-Less:Other special charges | ---- | ---- | ---- | --2.92M | ---16.01K | --3.18K | ---96.78K | --3.03M | ---- | ---- |
Income before tax | 96.86%-16.85K | 83.46%-158.39K | 89.93%-385.89K | -275.68%-7.06M | -41.33%-1.75M | -82.23%-535.75K | -957.64K | -2,134.98%-3.83M | -1.88M | -1.24M |
Income tax | ||||||||||
Earnings from equity interest net of tax | ||||||||||
Net income | 96.86%-16.85K | 83.46%-158.39K | 89.93%-385.89K | -275.68%-7.06M | -41.33%-1.75M | -82.23%-535.75K | -957.64K | -2,134.98%-3.83M | -1.88M | -1.24M |
Net income continuous operations | 96.86%-16.85K | 83.46%-158.39K | 89.93%-385.89K | -275.68%-7.06M | -41.33%-1.75M | -82.23%-535.75K | ---957.64K | -2,134.98%-3.83M | ---1.88M | ---1.24M |
Noncontrolling interests | ||||||||||
Net income attributable to the company | 96.86%-16.85K | 83.46%-158.39K | 89.93%-385.89K | -275.68%-7.06M | -41.33%-1.75M | -82.23%-535.75K | -957.64K | -2,134.98%-3.83M | -1.88M | -1.24M |
Preferred stock dividends | ||||||||||
Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Net income attributable to common stockholders | 96.86%-16.85K | 83.46%-158.39K | 89.93%-385.89K | -275.68%-7.06M | -41.33%-1.75M | -82.23%-535.75K | -957.64K | -2,134.98%-3.83M | -1.88M | -1.24M |
Diluted earnings per share | 97.74%-0.0002 | 78.72%-0.0021 | 87.50%-0.01 | -365.50%-0.13 | -117.79%-0.04 | 80.50%-0.01 | -0.01 | -166.67%-0.08 | -0.0279 | -0.0184 |
Basic earnings per share | 97.74%-0.0002 | 78.72%-0.0021 | 87.50%-0.01 | -365.50%-0.13 | -117.79%-0.04 | 80.50%-0.01 | -0.01 | -166.67%-0.08 | -0.0279 | -0.0184 |
Dividend per share | ||||||||||
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
No Data